Novo Nordisk A/S (NVO) Insider Trading & Ownership $66.00 +1.27 (+1.96%) Closing price 04/14/2025 03:58 PM EasternExtended Trading$65.98 -0.02 (-0.03%) As of 09:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock There is no recent insider trading on record for Novo Nordisk A/S, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get NVO Insider Trade Alerts Want to know when executives and insiders are buying or selling Novo Nordisk A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads Novo Nordisk A/S Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction9/4/2024John JamesU.S. Congress Member (R-MI)Sell$134.50$1,001 - $15,0001/19/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$106.95$15,001 - $50,0007/12/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$38.69$100,001 - $250,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$39.27$250,001 - $500,000 (Data available from 1/1/2013 forward) NVO Insider Trading Activity - Frequently Asked Questions What percentage of Novo Nordisk A/S stock is owned by insiders? 0.07% of Novo Nordisk A/S stock is owned by insiders. Learn more on NVO's insider holdings. Which members of congress are trading Novo Nordisk A/S? John James (R-MI) has sold shares of Novo Nordisk A/S in the last year totaling $8,000. Novo Nordisk A/S Key ExecutivesMr. Lars Fruergaard Jorgensen (Age 58)President, CEO & Member of Management Board Compensation: $4.84MMr. Karsten Munk Knudsen (Age 53)Executive VP, CFO & Member of the Management Board Compensation: $1.92MMr. Henrik Ehlers Wulff (Age 54)Executive VP of Product Supply, Quality & IT and Member of the Management Board Compensation: $1.93MMs. Camilla Sylvest (Age 52)Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Board Compensation: $1.89MDr. Martin Holst Lange (Age 54)Executive VP of Development & Member of the Management Board Compensation: $1.83MDr. Marcus Schindler Ph.D. (Age 58)EVP of Research & Early Development, Chief Scientific Officer & Member of the Management Board Compensation: $1.83MMr. Maziar Mike Doustdar (Age 54)Executive VP of International Operations & Member of the Management Board Mr. Douglas J. Langa (Age 58)Executive VP of North America Operations & Member of Management Board Mr. Ludovic Helfgott (Age 50)Executive VP, Head of Rare Disease & Member of Management Board Ms. Tania Sabroe (Age 47)Executive VP of Global People & Organisation and Member of Management Board More Insider Trading Tools from MarketBeat Related Companies NVS Insider Ownership AZN Insider Ownership SNY Insider Ownership GSK Insider Ownership TAK Insider Ownership ARGX Insider Ownership ONC Insider Ownership BNTX Insider Ownership TEVA Insider Ownership ITCI Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market This page (NYSE:NVO) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
